Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Immuneering Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 37 | 32 | −5 |
| Shares | 12.1M | 12.1M | −85.5K (−0.7%) |
| Value | $65.7M | $172.5M | +$106.8M (+162.5%) |
New holders (5)
Institutions that held Immuneering Corp at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 458,233 | $6.56M | 0.01% |
| Marshall Wace, LLP | 67,160 | $962.0K | 0.00% |
| Gsa Capital Partners LLP | 33,110 | $474.0K | 0.06% |
| Balyasny Asset Management LLC | 11,366 | $163.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 247 | $4.00K | 0.00% |
Sold out (10)
Institutions that held Immuneering Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Suvretta Capital Management, LLC | 200,000 | $1.08M |
| Renaissance Technologies LLC | 25,537 | $138.0K |
| Two Sigma Investments, LP | 17,138 | $93.0K |
| Cubist Systematic Strategies, LLC | 16,893 | $91.0K |
| Two Sigma Advisers, LP | 11,100 | $60.0K |
| Occudo Quantitative Strategies LP | 10,498 | $57.0K |
| Legal & General Group Plc | 1,591 | $9.00K |
| New York State Common Retirement Fund | 165 | $1.00K |
| Credit Suisse AG | 10 | $0 |
| Ellevest, Inc. | 7 | $0 |